Citadel Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $597M | Buy |
|
|||||
|
2021
Q1 | $383M | Buy |
|
|||||
|
2020
Q4 | $129M | Buy |
|
|||||
|
2020
Q3 | $62M | Sell |
|
|||||
|
2020
Q2 | $127M | Sell |
|
|||||
|
2020
Q1 | $258M | Buy |
|
|||||
|
2019
Q4 | $7.59M | Sell |
|
|||||
|
2019
Q3 | $8.53M | Sell |
|
|||||
|
2019
Q2 | $26.9M | Buy |
|
|||||
|
2019
Q1 | $9.53M | Sell |
|
|||||
|
2018
Q4 | $43.1M | Sell |
|
|||||
|
2018
Q3 | $188M | Sell |
|
|||||
|
2018
Q2 | $215M | Buy |
|
|||||
|
2018
Q1 | $77.3M | Sell |
|
|||||
|
2017
Q4 | $238M | Buy |
|
|||||
|
2017
Q3 | $103M | Sell |
|
|||||
|
2017
Q2 | $136M | Buy |
|
|||||
|
2017
Q1 | $12.6M | Buy |
|
|||||
|
2016
Q4 | $3.16M | Sell |
|
|||||
|
2016
Q3 | $26.6M | Sell |
|
|||||
|
2016
Q2 | $164M | Buy |
|
|||||
|
2016
Q1 | $7.6M | Buy |
|
|||||
|
2015
Q4 | $1.67M | Sell |
|
|||||
|
2015
Q3 | $11.4M | Sell |
|
|||||
|
2015
Q2 | $75M | Sell |
|
|||||
|
2015
Q1 | $198M | Buy |
|
|||||
|
2014
Q4 | $46.1M | Sell |
|
|||||
|
2014
Q3 | $49.8M | Sell |
|
|||||
|
2014
Q2 | $85.9M | Buy |
|
|||||
|
2014
Q1 | $68M | Buy |
|
|||||
|
2013
Q4 | $31.9M | Sell |
|
|||||
|
2013
Q3 | $175M | Buy |
|
|||||
|
2013
Q2 | $88.8M | Buy |
|